Results 131 to 140 of about 493,126 (165)

Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial

Lancet, The, 2022
Urs Fischer, Johannes Kaesmacher, Marc Ribo   +2 more
exaly  

Value of intravenous thrombolysis in endovascular treatment for large-vessel anterior circulation stroke: individual participant data meta-analysis of six randomised trials

Lancet, The, 2023
exaly  

Intravenous Fluid Administration

2019
Eugene C. Corbett, T. S. Dharmarajan
openaire   +1 more source

Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials

Lancet, The, 2010
Rüdiger von Kummer, Danilo S Toni, James C Grotta   +2 more
exaly  

Stent-Retriever Thrombectomy after Intravenous t-PA vs. t-PA Alone in Stroke

New England Journal of Medicine, 2015
Jeffrey L. Saver, Mayank Goyal, Alain Bonafe   +2 more
exaly  

Oral versus Intravenous Antibiotics for Bone and Joint Infection

New England Journal of Medicine, 2019
Ines Rombach, Rhea Zambellas, Martin A Mcnally   +2 more
exaly  

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Lancet, The, 2022
exaly  

Intravenous enoxaparin or unfractionated heparin in primary percutaneous coronary intervention for ST-elevation myocardial infarction: the international randomised open-label ATOLL trial

Lancet, The, 2011
Johanne Silvain, Charles Pollack, Frederic Adnet   +2 more
exaly  

Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis

Lancet, The, 1997
Peter Brown, Michael Swash
exaly  

Intravenous Drug Administration

1994
openaire   +1 more source